FDA Grants Soligenix Fast Track Designation for Dusquetide in the Treatment of Oral Lesions of Behçet's Disease

PRINCETON, N.J., Jan. 8, 2024 /PRNewswire/ -- Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an...

Related Keywords

United Kingdom ,Sudan ,Japan ,Iran ,Turkey ,China ,Canada ,British ,Robert Hancock ,Christopherj Schaber ,B Brett Finlay ,Biomedical Advanced Research ,University Of British Columbia ,Twitter ,Development Authority ,Soligenix Inc ,Exchange Commission ,Us Congress ,Nasdaq ,Us Development ,National Institute Of Allergy ,Prnewswire Soligenix Inc ,Defense Threat Reduction Agency ,Linkedin ,Our Public Health Solutions ,Drug Administration ,Chief Executive Officer ,British Columbia ,Middle East ,East Asia ,Public Health Solutions ,National Institute ,Infectious Diseases ,Project Bioshield ,Priority Review Voucher ,Markets ,